Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome.
<b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance an...
Ausführliche Beschreibung
Autor*in: |
Surucuoglu Suheyla [verfasserIn] Ozkutuk Nuri [verfasserIn] Celik Pinar [verfasserIn] Gazi Horu [verfasserIn] Dinc Gonul [verfasserIn] Kurutepe Semra [verfasserIn] Koroglu Galip [verfasserIn] Havlucu Yavuz [verfasserIn] Tuncay Gulgun [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2005 |
---|
Übergeordnetes Werk: |
In: Annals of Saudi Medicine - King Faisal Specialist Hospital and Research Centre, 2018, 25(2005), 4, Seite 313-318 |
---|---|
Übergeordnetes Werk: |
volume:25 ; year:2005 ; number:4 ; pages:313-318 |
Links: |
---|
Katalog-ID: |
DOAJ007858396 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ007858396 | ||
003 | DE-627 | ||
005 | 20230307024633.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2005 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ007858396 | ||
035 | |a (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Surucuoglu Suheyla |e verfasserin |4 aut | |
245 | 1 | 0 | |a Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. |
264 | 1 | |c 2005 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. | ||
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Ozkutuk Nuri |e verfasserin |4 aut | |
700 | 0 | |a Celik Pinar |e verfasserin |4 aut | |
700 | 0 | |a Gazi Horu |e verfasserin |4 aut | |
700 | 0 | |a Dinc Gonul |e verfasserin |4 aut | |
700 | 0 | |a Kurutepe Semra |e verfasserin |4 aut | |
700 | 0 | |a Koroglu Galip |e verfasserin |4 aut | |
700 | 0 | |a Havlucu Yavuz |e verfasserin |4 aut | |
700 | 0 | |a Tuncay Gulgun |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Annals of Saudi Medicine |d King Faisal Specialist Hospital and Research Centre, 2018 |g 25(2005), 4, Seite 313-318 |w (DE-627)320622738 |w (DE-600)2022900-8 |x 09754466 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2005 |g number:4 |g pages:313-318 |
856 | 4 | 0 | |u https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc |z kostenfrei |
856 | 4 | 0 | |u http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/0256-4947 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/0975-4466 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 25 |j 2005 |e 4 |h 313-318 |
author_variant |
s s ss o n on c p cp g h gh d g dg k s ks k g kg h y hy t g tg |
---|---|
matchkey_str |
article:09754466:2005----::rgeitnploayueclssnetrtrepeaecciiacaat |
hierarchy_sort_str |
2005 |
publishDate |
2005 |
allfields |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc DE-627 ger DE-627 rakwb eng Surucuoglu Suheyla verfasserin aut Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. Medicine R Ozkutuk Nuri verfasserin aut Celik Pinar verfasserin aut Gazi Horu verfasserin aut Dinc Gonul verfasserin aut Kurutepe Semra verfasserin aut Koroglu Galip verfasserin aut Havlucu Yavuz verfasserin aut Tuncay Gulgun verfasserin aut In Annals of Saudi Medicine King Faisal Specialist Hospital and Research Centre, 2018 25(2005), 4, Seite 313-318 (DE-627)320622738 (DE-600)2022900-8 09754466 nnns volume:25 year:2005 number:4 pages:313-318 https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc kostenfrei http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu kostenfrei https://doaj.org/toc/0256-4947 Journal toc kostenfrei https://doaj.org/toc/0975-4466 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2005 4 313-318 |
spelling |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc DE-627 ger DE-627 rakwb eng Surucuoglu Suheyla verfasserin aut Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. Medicine R Ozkutuk Nuri verfasserin aut Celik Pinar verfasserin aut Gazi Horu verfasserin aut Dinc Gonul verfasserin aut Kurutepe Semra verfasserin aut Koroglu Galip verfasserin aut Havlucu Yavuz verfasserin aut Tuncay Gulgun verfasserin aut In Annals of Saudi Medicine King Faisal Specialist Hospital and Research Centre, 2018 25(2005), 4, Seite 313-318 (DE-627)320622738 (DE-600)2022900-8 09754466 nnns volume:25 year:2005 number:4 pages:313-318 https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc kostenfrei http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu kostenfrei https://doaj.org/toc/0256-4947 Journal toc kostenfrei https://doaj.org/toc/0975-4466 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2005 4 313-318 |
allfields_unstemmed |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc DE-627 ger DE-627 rakwb eng Surucuoglu Suheyla verfasserin aut Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. Medicine R Ozkutuk Nuri verfasserin aut Celik Pinar verfasserin aut Gazi Horu verfasserin aut Dinc Gonul verfasserin aut Kurutepe Semra verfasserin aut Koroglu Galip verfasserin aut Havlucu Yavuz verfasserin aut Tuncay Gulgun verfasserin aut In Annals of Saudi Medicine King Faisal Specialist Hospital and Research Centre, 2018 25(2005), 4, Seite 313-318 (DE-627)320622738 (DE-600)2022900-8 09754466 nnns volume:25 year:2005 number:4 pages:313-318 https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc kostenfrei http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu kostenfrei https://doaj.org/toc/0256-4947 Journal toc kostenfrei https://doaj.org/toc/0975-4466 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2005 4 313-318 |
allfieldsGer |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc DE-627 ger DE-627 rakwb eng Surucuoglu Suheyla verfasserin aut Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. Medicine R Ozkutuk Nuri verfasserin aut Celik Pinar verfasserin aut Gazi Horu verfasserin aut Dinc Gonul verfasserin aut Kurutepe Semra verfasserin aut Koroglu Galip verfasserin aut Havlucu Yavuz verfasserin aut Tuncay Gulgun verfasserin aut In Annals of Saudi Medicine King Faisal Specialist Hospital and Research Centre, 2018 25(2005), 4, Seite 313-318 (DE-627)320622738 (DE-600)2022900-8 09754466 nnns volume:25 year:2005 number:4 pages:313-318 https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc kostenfrei http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu kostenfrei https://doaj.org/toc/0256-4947 Journal toc kostenfrei https://doaj.org/toc/0975-4466 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2005 4 313-318 |
allfieldsSound |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc DE-627 ger DE-627 rakwb eng Surucuoglu Suheyla verfasserin aut Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. Medicine R Ozkutuk Nuri verfasserin aut Celik Pinar verfasserin aut Gazi Horu verfasserin aut Dinc Gonul verfasserin aut Kurutepe Semra verfasserin aut Koroglu Galip verfasserin aut Havlucu Yavuz verfasserin aut Tuncay Gulgun verfasserin aut In Annals of Saudi Medicine King Faisal Specialist Hospital and Research Centre, 2018 25(2005), 4, Seite 313-318 (DE-627)320622738 (DE-600)2022900-8 09754466 nnns volume:25 year:2005 number:4 pages:313-318 https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc kostenfrei http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu kostenfrei https://doaj.org/toc/0256-4947 Journal toc kostenfrei https://doaj.org/toc/0975-4466 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2005 4 313-318 |
language |
English |
source |
In Annals of Saudi Medicine 25(2005), 4, Seite 313-318 volume:25 year:2005 number:4 pages:313-318 |
sourceStr |
In Annals of Saudi Medicine 25(2005), 4, Seite 313-318 volume:25 year:2005 number:4 pages:313-318 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Medicine R |
isfreeaccess_bool |
true |
container_title |
Annals of Saudi Medicine |
authorswithroles_txt_mv |
Surucuoglu Suheyla @@aut@@ Ozkutuk Nuri @@aut@@ Celik Pinar @@aut@@ Gazi Horu @@aut@@ Dinc Gonul @@aut@@ Kurutepe Semra @@aut@@ Koroglu Galip @@aut@@ Havlucu Yavuz @@aut@@ Tuncay Gulgun @@aut@@ |
publishDateDaySort_date |
2005-01-01T00:00:00Z |
hierarchy_top_id |
320622738 |
id |
DOAJ007858396 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ007858396</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307024633.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ007858396</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Surucuoglu Suheyla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ozkutuk Nuri</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Celik Pinar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gazi Horu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dinc Gonul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kurutepe Semra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Koroglu Galip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Havlucu Yavuz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tuncay Gulgun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Saudi Medicine</subfield><subfield code="d">King Faisal Specialist Hospital and Research Centre, 2018</subfield><subfield code="g">25(2005), 4, Seite 313-318</subfield><subfield code="w">(DE-627)320622738</subfield><subfield code="w">(DE-600)2022900-8</subfield><subfield code="x">09754466</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:313-318</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0256-4947</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0975-4466</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2005</subfield><subfield code="e">4</subfield><subfield code="h">313-318</subfield></datafield></record></collection>
|
author |
Surucuoglu Suheyla |
spellingShingle |
Surucuoglu Suheyla misc Medicine misc R Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. |
authorStr |
Surucuoglu Suheyla |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)320622738 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
09754466 |
topic_title |
Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome |
topic |
misc Medicine misc R |
topic_unstemmed |
misc Medicine misc R |
topic_browse |
misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Annals of Saudi Medicine |
hierarchy_parent_id |
320622738 |
hierarchy_top_title |
Annals of Saudi Medicine |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)320622738 (DE-600)2022900-8 |
title |
Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. |
ctrlnum |
(DE-627)DOAJ007858396 (DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc |
title_full |
Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome |
author_sort |
Surucuoglu Suheyla |
journal |
Annals of Saudi Medicine |
journalStr |
Annals of Saudi Medicine |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2005 |
contenttype_str_mv |
txt |
container_start_page |
313 |
author_browse |
Surucuoglu Suheyla Ozkutuk Nuri Celik Pinar Gazi Horu Dinc Gonul Kurutepe Semra Koroglu Galip Havlucu Yavuz Tuncay Gulgun |
container_volume |
25 |
format_se |
Elektronische Aufsätze |
author-letter |
Surucuoglu Suheyla |
author2-role |
verfasserin |
title_sort |
drug-resistant pulmonary tuberculosis in western turkey : prevalence, clinical characteristics and treatment outcome |
title_auth |
Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. |
abstract |
<b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. |
abstractGer |
<b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. |
abstract_unstemmed |
<b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
4 |
title_short |
Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome. |
url |
https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu https://doaj.org/toc/0256-4947 https://doaj.org/toc/0975-4466 |
remote_bool |
true |
author2 |
Ozkutuk Nuri Celik Pinar Gazi Horu Dinc Gonul Kurutepe Semra Koroglu Galip Havlucu Yavuz Tuncay Gulgun |
author2Str |
Ozkutuk Nuri Celik Pinar Gazi Horu Dinc Gonul Kurutepe Semra Koroglu Galip Havlucu Yavuz Tuncay Gulgun |
ppnlink |
320622738 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
up_date |
2024-07-03T14:32:03.967Z |
_version_ |
1803568675782918144 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ007858396</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307024633.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2005 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ007858396</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2fce9a6bd67a412ab3240f00e3f9bfdc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Surucuoglu Suheyla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><b<BACKGROUND</b< : Although high antituberculosis (anti-TB) drug resistance rates have been reported in Turkey, the clinical characteristics and implications for the outcome of anti-TB treatment have not been fully investigated. We determined the prevalence of anti-TB drug resistance and examined demographic data, clinical characteristics and treatment outcome in relation to patterns of resistance. METHODS: From the TB case registry of a university hospital and the two largest dispensaries in Manisa city, we identified all pulmonary TB cases with a culture-proven definitive diagnosis and antimicrobial susceptibility results for a 7-year period. We collected and analyzed demographic and clinical data and information on treatment outcome for those cases in relationship to anti-TB drug resistance. <b<RESULTS</b< : Of 355 <i<M. tuberculosis </i<strains, 71.5% were susceptible to streptomycin, isoniazid, rifampicin and ethambutol. Any drug resistance and multi-drug resistance (MDR ) rates were 21.1% and 7.3% and were higher in males (53% and 9%, respectively) than in females (22% and 1%, respectively). Drug resistance was significantly higher in old cases (acquired drug resistance) vs new cases (primary drug resistance), and was associated with treatment failure (<i<P</i<< 0.001). The prevalence of MDR was significantly higher in the old cases (22.4%) than in the new cases (4.4%) (<i<P</i<< 0.001). Symptoms, radiographic findings, associated diseases, and sputum smear positivity were unrelated to the development of resistance. The prevalence of any drug resistance and MDR was significantly higher in those with treatment failure than in patients with treatment success. <b<CONCLUSION</b< : High resistance rates, particularly for acquired MDR, indicate a need for improvement in the TB control programme in our region.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ozkutuk Nuri</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Celik Pinar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gazi Horu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dinc Gonul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kurutepe Semra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Koroglu Galip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Havlucu Yavuz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tuncay Gulgun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Saudi Medicine</subfield><subfield code="d">King Faisal Specialist Hospital and Research Centre, 2018</subfield><subfield code="g">25(2005), 4, Seite 313-318</subfield><subfield code="w">(DE-627)320622738</subfield><subfield code="w">(DE-600)2022900-8</subfield><subfield code="x">09754466</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:313-318</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2fce9a6bd67a412ab3240f00e3f9bfdc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=4;spage=313;epage=318;aulast=Surucuoglu</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0256-4947</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0975-4466</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2005</subfield><subfield code="e">4</subfield><subfield code="h">313-318</subfield></datafield></record></collection>
|
score |
7.3996496 |